A Distinct Microglial Cell Population Expressing Both CD86 and CD206 Constitutes a Dominant Type and Executes

Yan Zhang1,2,3, Yong Soo Park1,2, In-Beom Kim1,2,3,4

  • 1Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Insights

Microglial cells in retinal degeneration (RD) do not fit the M1/M2 classification. Instead, they exhibit dual CD86/CD206 expression, indicating a role in phagocytosis, not inflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Ophthalmology

Background:

  • Microglial cells are key regulators of inflammation in retinal degeneration (RD).
  • Conventional M1/M2 classification of microglia may not accurately reflect their function in the retina.

Purpose of the Study:

  • To investigate the spatiotemporal changes and functional classification of microglial cells during induced retinal degeneration.
  • To determine if M1/M2 markers accurately represent microglial function in RD.

Main Methods:

  • Induced retinal degeneration in mice using blue-light and NaIO3.
  • Immunolabeling for microglial markers (IBA1, P2RY12, CD86, CD206) and TUNEL assay for photoreceptor cell death.
  • Flow cytometry and qRT-PCR to analyze microglial populations and gene expression (Il-10, Il-6, Trem-2, Apoe, Lyz2).

Main Results:

  • Photoreceptor cell death was observed from 24 to 72 hours post-induction.
  • Microglial marker P2RY12 decreased while CD86 increased at 24 hours.
  • At 72 hours, CD86/CD206 double-labeled microglia were dominant and showed increased expression of Apoe, Trem2, and Lyz2, but not Il-6 or Il-10.

Conclusions:

  • Microglial cells in active retinal degeneration cannot be classified as strictly M1 or M2.
  • The majority of microglia in RD express both CD86 and CD206.
  • These dual-expressing microglia are primarily involved in phagocytosis rather than classical inflammation.

Related Concept Videos